Cannara Biotech Appoints Nicholas Fozard as CFO

MT newswire2026/09/01 13:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

09:00 AM EDT, 09/01/2026 (MT Newswires) -- Cannara Biotech (LOVE.TO) appointed Nicholas Fozard, as its Chief Financial Officer, it said in a statement on Tuesday. Fozard's appointment as CFO will take effect upon his receipt of the Health Canada security clearance needed of all of its officers and directors, it said. Most recently, Fozard served as the Vice President, Finance at Organigram Global. Sosiak, who served as the company's CFO from 2020 until his appointment as Chief Operating Officer on April 23, and who has continued to serve as interim CFO during the search, will now transition fully into his role as COO. Shares of the company closed unchanged at C$1.99 on Monday on the Toronto Stock Exchange.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.

华尔街见闻•2026/11/10 18:41